229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-14.16%
Negative net income growth while VUZI stands at 11.25%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
19.05%
D&A growth well above VUZI's 22.92%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
14.63%
Deferred tax of 14.63% while VUZI is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
No Data
No Data available this quarter, please select a different quarter.
109.85%
Slight usage while VUZI is negative at -19.64%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
43.75%
AR growth while VUZI is negative at -73.35%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
No Data
No Data available this quarter, please select a different quarter.
-12.70%
Both negative yoy AP, with VUZI at -192.98%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-40.00%
Negative yoy usage while VUZI is 352.14%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
50.00%
Lower 'other non-cash' growth vs. VUZI's 100.00%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
283.61%
Some CFO growth while VUZI is negative at -38.64%. John Neff would note a short-term liquidity lead over the competitor.
59.26%
Some CapEx rise while VUZI is negative at -18.60%. John Neff would see competitor possibly building capacity while we hold back expansions.
-49.50%
Negative yoy acquisition while VUZI stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
12.45%
Purchases growth of 12.45% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-26.94%
We reduce yoy sales while VUZI is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
150.00%
Growth well above VUZI's 6.90%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-3266.67%
Both yoy lines negative, with VUZI at -13.57%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-90.00%
Negative yoy issuance while VUZI is 124.06%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.